Newborn screening for spinal muscular atrophy

Project Details

Description

Project allow to perform newborn screening on spinal muscular atrophy that was started as Scientific project funded by Latvian Scientific Council (2020-2021) till the moment when spinal muscular atrophy will be included in governmental newborn screening program.
StatusFinished
Effective start/end date5/01/224/01/23

Collaborative partners

Total Funding

  • Novartis: €19,996.60

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Keywords

  • Spinal muscular atrophy
  • Newborn screening
  • genetic analyses
  • genetic screening
  • SMA

Field of Science

  • 3.2 Clinical medicine

Smart Specialization Area

  • Biomedicine, medical technologies and biotechnology

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.